Clinical Trials Browser

INDUSTRY × Multiple Myeloma × dexamethasone acetate × Clear all

NCT02555839 2025-03-28

Treatment of Relapsed/Refractory Multiple Myeloma (rrMM) With Pomalidomide in Clinical Practice

Multiple Myeloma

NCT03151811 2024-01-30

OCEAN

Phase 3 Terminated

495 enrolled 15 charts

Multiple Myeloma

NCT02294357 2023-11-01

Weekly 70 mg/m2 Carfilzomib for Multiple Myeloma Patients Refractory to 27 mg/m2 Carfilzomib

Phase 2 Terminated

Multiple Myeloma, Recurrence